Pharmacokinetic interaction between sodium valproate and mycophenolate in Renal allograft recipients

Transplantation

Volumn 88, Issue 9, 2009, Pages 1143-1145

  Annapandian, V M ^a   John, George T ^a   Mathew, Binu S ^a   Fleming, Denise H ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBAZAM; MYCOPHENOLIC ACID; PREDNISOLONE; TACROLIMUS; VALPROIC ACID;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; CASE REPORT; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTERIC COATED TABLET; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; MALE; MAXIMUM PLASMA CONCENTRATION; MOOD DISORDER; PRIORITY JOURNAL; SEIZURE;

ADOLESCENT; ADULT; ANTICONVULSANTS; AREA UNDER CURVE; AZATHIOPRINE; FEMALE; GLUCOCORTICOIDS; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; SEIZURES; TRANSPLANTATION, HOMOLOGOUS; VALPROIC ACID;

EID: 72949104529     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181bb99ff     Document Type: Letter

References (6)

1. Kiberd BA, Lawen J, Fraser AD, et al. Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation. Am J Transplant 2004;4: 1079.
2. Shaw LM, Holt DW, Oellerich M, et al. Current issues in therapeutic drug monitoring of mycophenolic acid: Report of a round table discussion. Ther Drug Monit 2001;23: 305.
3. Kuypers DRJ, de Jonge H, Naesens M, et al. Current target ranges of mycophenolic acid exposure and drug-related adverse events: A 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients. Clin Therapeut 2004; 30: 673.
4. Fleming DH, Mathew BS, John GT, et al. A six hour extrapolated sampling strategy for monitoring mycophenolic acid in renal transplant patients in the India subcontinent. J Postgrad Med 2006;52: 248.
5. Budde K, Bauer S, Hambach P, et al. Phar-macokinetic and pharmacodynamic comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil in maintenance renal transplant patients. Am J Transplant 2007; 7: 888.
6. Van Gelder T, Hilbrands LB, Vanrenterghem Y, et al. A randomized double blind multi-centre plasma concentration controlled study of the safety and efficacy of oral my-cophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation 1999;68: 261.